Paul-Peter Tak
CEO & Board Director

Paul Peter Tak

Paul Peter Tak is a business leader, academic, entrepreneur and clinician who has over 30 years’ experience in medicine as a prominent expert in Immunology, Internal Medicine, and Rheumatology. Paul Peter is currently the President, CEO, and Board Director of Candel Therapeutics, the Co-Founder and Board Director of Sitryx Therapeutics, and Board Director of Levicept and Citryll.

Alongside his industry career, Paul Peter has dedicated much of his life to academia and advancing our understanding in medicine. He has served as Professor of Medicine at the University of Amsterdam and holds numerous honours for his service to medicine, with a special focus on Immunology and Rheumatology.

President and CEO, Paul Peter Tak, MD, PhD, FMedSci, discussed Candel’s development of multimodal biological immunotherapies to fight cancer and potentially alter the future of cancer immunotherapy in the below interview with Healthcare Future.

Be sure to connect with President and CEO,
@paulpetertak, MD, PhD, FMedSci, and Interim CFO, Charles Schoch at @IAmBiotech
CEO & Investor Conference in New York.

The team is looking forward to mingling with industry contacts.

#BIOCEO24

Check out my latest article: Building trust is only half the story – it’s how you maintain it that matters via @LinkedIn

Load More
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.